GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: AMG-403 | JNJ-42160443
                                 
                                                         
                            Compound class: 
                                                            Antibody
                                 
                                
                                    
                                        Comment: Fulranumab was an investigational, fully human IgG2κ monoclonal antibody targeting nerve growth factor (NGF) [1,6]. 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                    Peptide sequence information for this antibody is available from its IMGT/mAb-DB record. BLAST peptide sequence analysis reveals identical matches to peptide sequences submitted with patent US7601818 [9], which belong to antibody clone 4D4 therein.  | 
                                    
Classification ![]()  | 
                                                    |
| Compound class | Antibody | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 9373 | fulranumab | 
Synonyms ![]()  | 
                                                        
| AMG-403 | JNJ-42160443 | 
Database Links ![]()  | 
                                                        |
| Specialist databases | |
| IMGT/mAb-DB | 363 | 
| Other databases | |
| GtoPdb PubChem SID | 310264744 | 
| Search PubMed clinical trials | fulranumab | 
| Search PubMed titles | fulranumab | 
| Search PubMed titles/abstracts | fulranumab |